Pulmatrix, Inc. (PULM)
NASDAQ: PULM · Real-Time Price · USD
4.935
+0.285 (6.13%)
At close: Oct 8, 2025, 4:00 PM EDT
4.990
+0.055 (1.11%)
After-hours: Oct 8, 2025, 7:56 PM EDT
Pulmatrix Market Cap
Pulmatrix has a market cap or net worth of $18.02 million as of October 8, 2025. Its market cap has increased by 125.34% in one year.
Market Cap
18.02M
Enterprise Value
11.63M
1-Year Change
125.34%
Ranking
Category
Stock Price
$4.94
Market Cap Chart
Since June 16, 2015, Pulmatrix's market cap has decreased from $165.85M to $18.02M, a decrease of -89.13%. That is a compound annual growth rate of -19.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2025 | 16.98M | -33.38% |
| Dec 31, 2024 | 25.49M | 275.27% |
| Dec 29, 2023 | 6.79M | -51.89% |
| Dec 30, 2022 | 14.12M | -42.64% |
| Dec 31, 2021 | 24.61M | -39.88% |
| Dec 31, 2020 | 40.94M | 138.12% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 753.98B |
| Johnson & Johnson | 454.31B |
| AbbVie | 413.22B |
| UnitedHealth Group | 326.22B |
| Novo Nordisk | 264.73B |
| AstraZeneca | 264.35B |
| Novartis AG | 256.18B |
| Abbott Laboratories | 234.25B |